Possible Role of Intestinal Fatty Acid Oxidation in the Eating-Inhibitory Effect of the PPAR-α Agonist Wy-14643 in High-Fat Diet Fed Rats

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Karimian Azari, Elnaz ^a   Leitner, Claudia ^a,b   Jaggi, Thomas ^a   Langhans, Wolfgang ^a   Mansouri, Abdelhak ^a  

^a ETH ZURICH   (Switzerland)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; CARNITINE PALMITOYLTRANSFERASE I; FAT DROPLET; FATTY ACID; HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PIRINIXIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DUODENUM; FATTY ACID OXIDATION; FEEDING BEHAVIOR; FOOD INTAKE; INTESTINE; JEJUNUM; KETOGENESIS; LIPID DIET; LIVER; MALE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; RAT; RESPIRATORY QUOTIENT;

3-HYDROXYBUTYRIC ACID; ANIMALS; CARNITINE O-PALMITOYLTRANSFERASE; DIET, HIGH-FAT; ENERGY METABOLISM; FATTY ACIDS; FEEDING BEHAVIOR; GENE EXPRESSION REGULATION; HYDROXYMETHYLGLUTARYL-COA SYNTHASE; INTESTINES; JEJUNUM; LIPID METABOLISM; MALE; OXIDATION-REDUCTION; PPAR ALPHA; PYRIMIDINES; RATS;

EID: 84884227355     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074869     Document Type: Article

References (60)

1. Kaidar-Person O, Bar-Sela G, Person B, (2011) The two major epidemics of the twenty- first century: obesity and cancer. Obes Surg 21: 1792-1797. doi:10.1007/s11695-011-0490-2. PubMed: 21842287.
2. Swinburn B, Sacks G, Ravussin E, (2009) Increased food energy supply is more than sufficient to explain the US epidemic of obesity. Am J Clin Nutr 90: 1453-1456. doi:10.3945/ajcn.2009.28595. PubMed: 19828708.
3. Langhans W, Geary N, (2010) Overview of the physiological control of eating. Forum Nutr 63: 9-53. PubMed: 19955772.
4. Schwartz MW, Woods SC, Porte D Jr., Seeley RJ, Baskin DG, (2000) Central nervous system control of food intake. Nature 404: 661-671. PubMed: 10766253.
5. Horn CC, Ji H, Friedman MI, (2004) Etomoxir, a fatty acid oxidation inhibitor, increases food intake and reduces hepatic energy status in rats. Physiol Behav 81: 157-162. doi:10.1016/j.physbeh.2004.01.007. PubMed: 15059695.
6. Friedman MI, (1995) Control of energy intake by energy metabolism. Am J Clin Nutr 62: 1096S-1100S. PubMed: 7484927.
7. Scharrer E, Langhans W, (1986) Control of food intake by fatty acid oxidation. Am J Physiol 250: R1003-R1006. PubMed: 3717372.
8. Leonhardt M, Langhans W, (2004) Fatty acid oxidation and control of food intake. Physiol Behav 83: 645-651. doi:10.1016/j.physbeh.2004.07.033. PubMed: 15621070.
9. Fu J, Oveisi F, Gaetani S, Lin E, Piomelli D, (2005) Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats. Neuropharmacology 48: 1147-1153. doi:10.1016/j.neuropharm.2005.02.013. PubMed: 15910890.
10. Berger J, Moller DE, (2002) The mechanisms of action of PPARs. Annu Rev Med 53: 409-435. doi:10.1146/annurev.med.53.082901.104018. PubMed: 11818483.
11. Montagner A, Rando G, Degueurce G, Leuenberger N, Michalik L, et al. (2011) New insights into the role of PPARs. Prostaglandins Leukot Essent Fatty Acids 85: 235-243. doi:10.1016/j.plefa.2011.04.016. PubMed: 21778043.
12. Motojima K, Passilly P, Peters JM, Gonzalez FJ, Latruffe N, (1998) Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner. J Biol Chem 273: 16710-16714. doi:10.1074/jbc.273.27.16710. PubMed: 9642225.
13. van Raalte DH, Li M, Pritchard PH, Wasan KM, (2004) Peroxisome proliferator-activated receptor (PPAR)-alpha: a pharmacological target with a promising future. Pharm Res 21: 1531-1538. doi:10.1023/B:PHAM.0000041444.06122.8d. PubMed: 15497675.
14. Uchida A, Slipchenko MN, Cheng JX, Buhman KK, (2011) Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, alters triglyceride metabolism in enterocytes of mice. Biochim Biophys Acta 1811: 170-176. doi:10.1016/j.bbalip.2010.12.011. PubMed: 21215818.
15. Decara JM, Romero-Cuevas M, Rivera P, Macias-Gonzalez M, Vida M, et al. (2012) Elaidyl-sulfamide, an oleoylethanolamide-modelled PPARalpha agonist, reduces body weight gain and plasma cholesterol in rats. Dis Model. J Mech 5: 660-670.
16. Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, et al. (1999) Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest 103: 1489-1498. doi:10.1172/JCI6223. PubMed: 10359558.
17. Escher P, Braissant O, Basu-Modak S, Michalik L, Wahli W, et al. (2001) Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding. Endocrinology 142: 4195-4202. doi:10.1210/en.142.10.4195. PubMed: 11564675.
18. Bünger M, van den Bosch HM, van der Meijde J, Kersten S, Hooiveld GJ, et al. (2007) Genome-wide analysis of PPARalpha activation in murine small intestine. Physiol Genomics 30: 192-204. doi:10.1152/physiolgenomics.00198.2006. PubMed: 17426115.
19. de Vogel-van den Bosch HM, Bünger M, de Groot PJ, Bosch-Vermeulen H, Gjej, Hooiveldet al. (2008) PPARalpha-mediated effects of dietary lipids on intestinal barrier gene expression. Bmc Genomics 9: 231-. PubMed: 18489776.
20. Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W (1996) Differential expression of peroxisome proliferator-activated receptors(PPARs): tissue distribution of PPAR-alpha; -. (1996) beta, and-gamma in the adult rat. Endocrinology 137: 354-366. doi:10.1210/en.137.1.354. PubMed: 8536636.
21. Dreyer C, Krey G, Keller H, Givel F, Helftenbein G, et al. (1992) Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68: 879-887. doi:10.1016/0092-8674(92)90031-7. PubMed: 1312391.
22. Fu J, Gaetani S, Oveisi F, Lo Verme J, Serrano A, et al. (2003) Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature 425: 90-93. doi:10.1038/nature01921. PubMed: 12955147.
23. Rodríguez de Fonseca F, Navarro M, Gómez R, Escuredo L, Nava F, et al. (2001) An anorexic lipid mediator regulated by feeding. Nature 414: 209-212. doi:10.1038/35102582. PubMed: 11700558.
24. Gómez R, Navarro M, Ferrer B, Trigo JM, Bilbao A, et al. (2002) A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J Neurosci 22: 9612-9617. PubMed: 12417686.
25. Gaetani S, Fu J, Cassano T, Dipasquale P, Romano A, et al. (2010) The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin. J Neurosci 30: 8096-8101. doi:10.1523/JNEUROSCI.0036-10.2010. PubMed: 20554860.
26. Baumgartner I, Pacheco-López G, Rüttimann EB, Arnold M, Asarian L, et al. (2010) Hepatic-portal vein infusions of glucagon-like peptide-1 reduce meal size and increase c-Fos expression in the nucleus tractus solitarii, area postrema and central nucleus of the amygdala in rats. J Neuroendocrinol 22: 557-563. doi:10.1111/j.1365-2826.2010.01995.x. PubMed: 20298455.
27. Silberbauer CJ, Surina-Baumgartner DM, Arnold M, Langhans W, (2000) Prandial lactate infusion inhibits spontaneous feeding in rats. Am J Physiol Regul Integr Comp Physiol 278: R646-R653. PubMed: 10712284.
28. Rüttimann EB, Arnold M, Hillebrand JJ, Geary N, Langhans W, (2009) Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms. Endocrinology 150: 1174-1181. PubMed: 18948395.
29. Surina-Baumgartner DM, Langhans W, Geary N, (1995) Hepatic portal insulin antibody infusion increases, but insulin does not alter, spontaneous meal size in rats. Am J Physiol 269: R978-R982. PubMed: 7503325.
30. Balkan B, Li X, (2000) Portal GLP-1 administration in rats augments the insulin response to glucose via neuronal mechanisms. Am J Physiol Regul Integr Comp Physiol 279: R1449-R1454. PubMed: 11004015.
31. Wiersma J, Kastelijn J, (1986) Haematological, immunological and endocrinological aspects of chronic high frequency blood sampling in rats with replacement by fresh or preserved donor blood. Lab Anim 20: 57-66. doi:10.1258/002367786781062115. PubMed: 3951195.
32. Scheurink AJ, Steffens AB, (1990) Central and peripheral control of sympathoadrenal activity and energy metabolism in rats. Physiol Behav 48: 909-920. doi:10.1016/0031-9384(90)90248-3. PubMed: 2087525.
33. Langhans W, (1991) Hepatic and intestinal handling of metabolites during feeding in rats. Physiol Behav 49: 1203-1209. doi:10.1016/0031-9384(91)90352-O. PubMed: 1896503.
34. Riediger T, Cordani C, Potes CS, Lutz TA, (2010) Involvement of nitric oxide in lipopolysaccharide induced anorexia. Pharmacol Biochem Behav 97: 112-120. doi:10.1016/j.pbb.2010.04.015. PubMed: 20430051.
35. Yuan H, Li N, Lai Y, (2009) Evaluation of in vitro models for screening alkaline phosphatase-mediated bioconversion of phosphate ester prodrugs. Drug Metab Dispos 37: 1443-1447. doi:10.1124/dmd.108.026245. PubMed: 19372225.
36. Prip-Buus C, Cohen I, Kohl C, Esser V, McGarry JD, et al. (1998) Topological and functional analysis of the rat liver carnitine palmitoyltransferase 1 expressed in Saccharomyces cerevisiae. FEBS Lett 429: 173-178. doi:10.1016/S0014-5793(98)00584-5. PubMed: 9650584.
37. Park MK, Han Y, Kim MS, Seo E, Kang S, et al. (2012) Reduction of Food Intake by Fenofibrate is Associated with Cholecystokinin Release in Long-Evans Tokushima Rats. Korean J Physiol Pharmacol 16: 181-186. doi:10.4196/kjpp.2012.16.3.181. PubMed: 22802699.
38. Piomelli D, (2013) A fatty gut feeling. Trends Endocrinol Metab 24: 332-341. doi:10.1016/j.tem.2013.03.001. PubMed: 23567058.
39. Diep TA, Madsen AN, Holst B, Kristiansen MM, Wellner N, et al. (2011) Dietary fat decreases intestinal levels of the anorectic lipids through a fat sensor. FASEB J 25: 765-774. doi:10.1096/fj.10-166595. PubMed: 20959516.
40. Gaetani S, Oveisi F, Piomelli D, (2003) Modulation of meal pattern in the rat by the anorexic lipid mediator oleoylethanolamide. Neuropsychopharmacology 28: 1311-1316. doi:10.1038/sj.npp.1300166. PubMed: 12700681.
41. Zorrilla EP, Inoue K, Fekete EM, Tabarin A, Valdez GR, et al. (2005) Measuring meals: structure of prandial food and water intake of rats. Am J Physiol Regul Integr Comp Physiol 288: R1450-R1467. doi:10.1152/ajpregu.00175.2004. PubMed: 15637168.
42. Langhans W, Scharrer E, (1987) Role of fatty acid oxidation in control of meal pattern. Behav Neural Biol 47: 7-16. doi:10.1016/S0163-1047(87)90112-9. PubMed: 3566693.
43. Mansouri A, Aja S, Moran TH, Ronnett G, Kuhajda FP, et al. (2008) Intraperitoneal injections of low doses of C75 elicit a behaviorally specific and vagal afferent-independent inhibition of eating in rats. Am J Physiol Regul Integr Comp Physiol 295: R799-R805. doi:10.1152/ajpregu.90381.2008. PubMed: 18667714.
44. Langhans W, Leitner C, Arnold M, (2011) Dietary fat sensing via fatty acid oxidation in enterocytes: possible role in the control of eating. Am J Physiol Regul Integr Comp Physiol 300: R554-R565. doi:10.1152/ajpregu.00610.2010. PubMed: 21148477.
45. Rodríguez JC, Gil-Gómez G, Hegardt FG, Haro D, (1994) Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids. J Biol Chem 269: 18767-18772. PubMed: 7913466.
46. Tamura K, Ono A, Miyagishima T, Nagao T, Urushidani T, (2006) Profiling of gene expression in rat liver and rat primary cultured hepatocytes treated with peroxisome proliferators. J Toxicol Sci 31: 471-490. doi:10.2131/jts.31.471. PubMed: 17202761.
47. Serra D, Casals N, Asins G, Royo T, Ciudad CJ, et al. (1993) Regulation of mitochondrial 3-hydroxy-3-methylglutaryl-coenzyme A synthase protein by starvation, fat feeding, and diabetes. Arch Biochem Biophys 307: 40-45. doi:10.1006/abbi.1993.1557. PubMed: 7902069.
48. Thumelin S, Forestier M, Girard J, Pegorier JP, (1993) Developmental changes in mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene expression in rat liver, intestine and kidney. Biochem J 292(2):: 493-496. PubMed: 8099282.
49. Gonzalez FJ, Peters JM, Cattley RC, (1998) Mechanism of action of the nongenotoxic peroxisome proliferators: role of the peroxisome proliferator-activator receptor alpha. J Natl Cancer Inst 90: 1702-1709. doi:10.1093/jnci/90.22.1702. PubMed: 9827524.
50. Hegardt FG, (1999) Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase: a control enzyme in ketogenesis. Biochem J 338(3):: 569-582. doi:10.1042/0264-6021:3380569.
51. Vilà-Brau A, De Sousa-Coelho AL, Mayordomo C, Haro D, Marrero PF, (2011) Human HMGCS2 regulates mitochondrial fatty acid oxidation and FGF21 expression in HepG2 cell line. J Biol Chem 286: 20423-20430. doi:10.1074/jbc.M111.235044. PubMed: 21502324.
52. Kondo H, Minegishi Y, Komine Y, Mori T, Matsumoto I, et al. (2006) Differential regulation of intestinal lipid metabolism-related genes in obesity-resistant A/J vs. obesity-prone C57BL/6J mice. Am J Physiol Endocrinol Metab 291: E1092-E1099. doi:10.1152/ajpendo.00583.2005. PubMed: 16822957.
53. Mochizuki K, Suruga K, Yagi E, Takase S, Goda T, (2001) The expression of PPAR-associated genes is modulated through postnatal development of PPAR subtypes in the small intestine. Biochim Biophys Acta 1531: 68-76. doi:10.1016/S0167-4889(01)00071-4. PubMed: 11278173.
54. Colin S, Briand O, Touche V, Wouters K, Baron M, et al. (2012) Activation of intestinal peroxisome proliferator-activated receptor-alpha increases high-density lipoprotein production. Eur Heart J.
55. Lagakos WS, Gajda AM, Agellon L, Binas B, Choi V, et al. (2011) Different functions of intestinal and liver-type fatty acid-binding proteins in intestine and in whole body energy homeostasis. Am J Physiol Gastrointest Liver Physiol 300: G803-G814. doi:10.1152/ajpgi.00229.2010. PubMed: 21350192.
56. Murase T, Aoki M, Wakisaka T, Hase T, Tokimitsu I, (2002) Anti-obesity effect of dietary diacylglycerol in C57BL/6J mice: dietary diacylglycerol stimulates intestinal lipid metabolism. J Lipid Res 43: 1312-1319. PubMed: 12177175.
57. Postic C, Girard J, (2008) Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 118: 829-838. doi:10.1172/JCI34275. PubMed: 18317565.
58. Langhans W, Pantel K, Scharrer E, (1985) Ketone kinetics and D-(-)-3-hydroxybutyrate-induced inhibition of feeding in rats. Physiol Behav 34: 579-582. doi:10.1016/0031-9384(85)90052-6. PubMed: 4011739.
59. Tabarin A, Diz-Chaves Y, Carmona Mdel C, Catargi B, Zorrilla EP, et al. (2005) Resistance to diet-induced obesity in mu-opioid receptor-deficient mice: evidence for a "thrifty gene". Diabetes 54: 3510-3516. doi:10.2337/diabetes.54.12.3510. PubMed: 16306369.
60. Scharrer E, (1999) Control of food intake by fatty acid oxidation and ketogenesis. Nutrition 15: 704-714. doi:10.1016/S0899-9007(99)00125-2. PubMed: 10467616.